Back to Search
PRIYA THAKER, PHARMD
PHARMD
Pharmacist
NPI: 1336572833Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PS51047(FL)
Research & Publications (20)
The value of perioperative imaging in patients with uterine sarcomas.
PMID 19577795·Gynecol Oncol·2009
8-other
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
PMID 19470935·J Clin Oncol·2009
8-other
The role of PET/CT in the management of patients with cervical cancer: practice patterns of the members of the Society of Gynecologic Oncologists.
PMID 19446317·Gynecol Oncol·2009
8-other
Functional significance of VEGFR-2 on ovarian cancer cells.
PMID 19058181·Int J Cancer·2009
7-preclinical
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
PMID 18929403·Gynecol Oncol·2009
8-other
Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
PMID 18922643·Cancer Treat Rev·2009
6-review
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
PMID 18395047·Am J Obstet Gynecol·2008
7-preclinical
Placental-site trophoblastic tumors: a case of resistant pulmonary metastasis.
PMID 18227827·Nat Clin Pract Oncol·2008
5-case
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
PMID 17974982·Cancer Res·2007
7-preclinical
Value of HPV testing in follow-up of treated high-risk CIN1: a study by Alonso et al.
PMID 17904992·Am J Obstet Gynecol·2007
8-other
Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination.
PMID 17724124·J Cell Biol·2007
7-preclinical
Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
PMID 17689656·Am J Obstet Gynecol·2007
8-other
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
PMID 17403394·Am J Obstet Gynecol·2007
5-case
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
PMID 17210709·Cancer Res·2007
7-preclinical
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
PMID 17077358·J Natl Cancer Inst·2006
7-preclinical
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
PMID 16969087·Cancer Biol Ther·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14075 BISCAYNE BLVD, T-1038
NORTH MIAMI BEACH, FL 33181 - Phone
- (305) 944-8103
Quick Facts
- NPI
- 1336572833
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile